By registering its manufacturing facility in the UAE market as the first pharmaceutical company from Pakistan, Searle Company Limited (PSX: SEARL) has made history.
According to a stock filing at the Pakistan Stock Exchange, “The Searle Company Limited (the “Company”) is pleased to announce that the Ministry of Health and Prevention of the United Arab Emirates has approved and registered the Company’s manufacturing site.
The filing also stated that Searle was rapidly expanding in a number of continents, including South Asia, Southeast Asia, Africa, Francophone Africa, the GCC, the Commonwealth of Independent States (CIS), Canada, Europe, and Latin America (EU and LATAM), among others.
By registering its manufacturing facility in the UAE market as the first pharmaceutical company from Pakistan, Searle Company Limited (PSX: SEARL) has made history.
According to a stock filing at the Pakistan Stock Exchange, “The Searle Company Limited (the “Company”) is pleased to announce that the Ministry of Health and Prevention of the United Arab Emirates has approved and registered the Company’s manufacturing site.
The filing also stated that Searle was rapidly expanding in a number of continents, including South Asia, Southeast Asia, Africa, Francophone Africa, the GCC, the Commonwealth of Independent States (CIS), Canada, Europe, and Latin America (EU and LATAM), among others.
